Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × talquetamab × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 27 Recurrence 4 Hematologic Neoplasms 2 Waldenstrom Macroglobulinemia 1 Neoplasm, Residual 1 Cytokine Release Syndrome 1

Interventions

Dexamethasone 11 daratumumab 6 Bortezomib 6 Cyclophosphamide 5 venetoclax 3 ixazomib 3 belantamab mafodotin 3 Specimen Handling 3 Focal Adhesion Protein-Tyrosine Kinases 3 Calcium Dobesilate 3 pomalidomide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 auricularum 2 X-Rays 2 Polymerase Chain Reaction 2 Phantoms, Imaging 2 Magnetic Resonance Spectroscopy 2 Clinical Protocols 2 Biopsy 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 siltuximab 1 isatuximab 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Spectrometry, Fluorescence 1 Positron-Emission Tomography 1 Pharmaceutical Preparations 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡